Key result
Preexisting mitral regurgitation is linked to higher 1-year heart failure risk after TAVR.
Why the study?
The mechanisms and clinical implications of mitral regurgitation in patients with severe aortic stenosis undergoing TAVR were not well understood.
Observational (n=140)
p-value: p=0.012
INTRODUCTION: This study aimed to investigate the mechanisms and clinical implications of mitral regurgitation (MR) in patients with severe aortic stenosis (AS) who received transcatheter aortic valve replacement (TAVR). METHODS: We conducted retrospective echocardiographic analyses at baseline and 6 months after TAVR in 140 patients with symptomatic AS (85 ± 5 years) who underwent TAVR. We defined significant MR as ≥ moderate based on evaluation of transthoracic echocardiography (TTE). RESULTS: There were 48 patients (34%) with preexisting MR at the baseline. Among measured TTE parameters, end-systolic wall stress (ESWS), mitral annulus area, and mitral valve thickening index were independent factors associated with preexisting MR (odds ratio [OR]: 1.013, 95% confidence interval [CI]: 1.005-1.021; OR: 1.740, 95% CI: 1.314-2.376; OR: 2.306, 95% CI: 1.426-3.848; respectively). Six months after TAVR, there were 34 patients with post-existing MR, A history of atrial fibrillation and ESWS after TAVR were independent factors (OR: 3.013, 95% CI: 1.208-7.556; OR: 1.013, 95% CI: 1.000-1.023; respectively). The Kaplan-Meier plot indicated that preexisting MR was a risk factor for heart failure-related events within 1 year of discharge after TAVR (p = .012). CONCLUSIONS: In patients who underwent TAVR for severe AS, preexisting MR was associated with having a thickened mitral valve and large mitral annulus size induced by high ESWS. These patients may have worse prognosis after TAVR and should be closely monitored in the long term.
No takes yet. Share an insight, caveat, or question.
Horinouchi et al. (2023) conducted an observational in Severe aortic stenosis (n=140). Preexisting mitral regurgitation vs. No preexisting mitral regurgitation was evaluated on Heart failure-related events within 1 year of discharge (p=0.012). Preexisting mitral regurgitation in patients undergoing TAVR for severe aortic stenosis was a significant risk factor for heart failure-related events within 1 year of discharge (p=0.012).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: